The US Food and Drug Administration has qualified the Patient-Reported Outcomes with LASIK Symptoms and Satisfaction – or PROWL-SS – as a scientifically valid tool. The agency qualified PROWL-SS through its Medical Device Development Tools (MDDT) program, which was designed to expedite the approval process for devices that incorporate emerging technology.
LASIK (laser-assisted in situ keratomileusis) is one of the most common elective surgeries in the US. An estimated 10 million Americans have had LASIK since it was first approved by...